Solicitation of Nominations for Membership on the Secretary's Advisory Committee on Human Research Protections; Correction, 20666 [2024-06362]
Download as PDF
20666
Federal Register / Vol. 89, No. 58 / Monday, March 25, 2024 / Notices
paccarb on the Upcoming Meetings
page.
The meeting is scheduled to be
held on May 21–22, 2024, from 9 a.m.
to 4 p.m. ET (times are tentative and
subject to change). The confirmed times
and agenda items for the meeting will be
posted on the website for the PACCARB
at https://www.hhs.gov/paccarb when
this information becomes available. Preregistration for attending the meeting is
strongly suggested and should be
completed no later than May 16, 2024.
ADDRESSES: The meeting will be held inperson at the Westin Tyson’s Corner,
7801 Leesburg Pike, Falls Church, VA,
22043. The meeting will also be live
streamed and can be accessed through a
live webcast on the day of the meeting.
Additional instructions regarding
attending this meeting virtually will be
posted at least one week prior to the
meeting at: https://www.hhs.gov/
paccarb.
DATES:
khammond on DSKJM1Z7X2PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Jomana Musmar, M.S., Ph.D.,
Designated Federal Officer, Presidential
Advisory Council on Combating
Antibiotic-Resistant Bacteria, Office of
the Assistant Secretary for Health, U.S.
Department of Health and Human
Services, 1101 Wootton Parkway,
Rockville, MD 20852. Phone: 202–746–
1512; Email: CARB@hhs.gov.
SUPPLEMENTARY INFORMATION: The
Presidential Advisory Council on
Combating Antibiotic-Resistant Bacteria
(PACCARB), established by Executive
Order 13676, is continued by Section
505 of Public Law 116–22, the
Pandemic and All-Hazards
Preparedness and Advancing Innovation
Act of 2019 (PAHPAIA). Activities and
duties of the PACCARB are governed by
the provisions of the Federal Advisory
Committee Act (FACA), Public Law 92–
463, as amended (5 U.S.C. App.), which
sets forth standards for the formation
and use of federal advisory committees.
The PACCARB shall advise and
provide information and
recommendations to the Secretary of
Health and Human Services (Secretary)
regarding programs and policies
intended to reduce or combat antibioticresistant bacteria that may present a
public health threat and improve
capabilities to prevent, diagnose,
mitigate, or treat such resistance. The
PACCARB shall function solely for
advisory purposes.
Such advice, information, and
recommendations may be related to
improving: the effectiveness of
antibiotics; research and advanced
research on, and the development of,
improved and innovative methods for
VerDate Sep<11>2014
18:08 Mar 22, 2024
Jkt 262001
combating or reducing antibiotic
resistance, including new treatments,
rapid point-of-care diagnostics,
alternatives to antibiotics, including
alternatives to animal antibiotics, and
antimicrobial stewardship activities;
surveillance of antibiotic-resistant
bacterial infections, including publicly
available and up-to-date information on
resistance to antibiotics; education for
health care providers and the public
with respect to up-to-date information
on antibiotic resistance and ways to
reduce or combat such resistance to
antibiotics related to humans and
animals; methods to prevent or reduce
the transmission of antibiotic-resistant
bacterial infections; including
stewardship programs; and coordination
with respect to international efforts in
order to inform and advance the United
States capabilities to combat antibiotic
resistance.
The focus of the May 21–22, 2024,
meeting will be to deliberate and vote
on the Global Antimicrobial Resistance
Working Group report to the Secretary
of Health and Human Services. The
remainder of the public meeting will
include updates on AMR in conflict
zones, the environment, and the voice of
the patient. The meeting agenda will be
posted on the PACCARB website at
https://www.hhs.gov/paccarb when it has
been finalized. All agenda items are
tentative and subject to change.
Instructions regarding attending the
meeting virtually will be posted at least
one week prior to the meeting at: https://
www.hhs.gov/paccarb. Members of the
public will have the opportunity to
provide comments during the May
meeting by pre-registering online at
https://www.hhs.gov/paccarb; preregistration is required for participation
in this session with limited spots
available. Written public comments can
also be emailed to CARB@hhs.gov by
midnight May 14, 2024, and should be
limited to no more than one page. All
public comments received prior to May
14, 2024, will be provided to the
PACCARB members. Additionally,
companies or organizations working to
combat antimicrobial resistance my
share their innovation during the May
meeting by pre-registering to speak
during the meeting’s Innovation
Spotlight. Pre-registration online at
https://www.hhs.gov/paccarb is required
for participation in this session, and
limited spots are available.
PO 00000
Dated: March 14, 2024.
Jomana F. Musmar,
Designated Federal Officer, Presidential
Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant
Secretary for Health.
[FR Doc. 2024–06157 Filed 3–22–24; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Nominations for
Membership on the Secretary’s
Advisory Committee on Human
Research Protections; Correction
Office of the Assistant
Secretary for Health, Office for
Infectious Disease and HIV/AIDS Policy,
Office of the Secretary, Department of
Health and Human Services (HHS).
ACTION: Notice; correction.
AGENCY:
HHS published a document in
the Federal Register of March 12, 2024,
announcing the Presidential Advisory
Council on HIV/AIDS (PACHA) 80th
full council meeting. Due to unforeseen
circumstances, there has been an update
in meeting location.
FOR FURTHER INFORMATION CONTACT:
Caroline Talev, caroline.talev@hhs.gov,
(202) 795–7622.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Correction
In the Federal Register of March 12,
2024, in FR Doc. 2024–05183, on page
17859, third column, correct the
ADDRESSES caption to read:
ADDRESSES: The public meeting will
now be held at the UT School of Public
Health, 1200 Pressler Street in Houston,
Texas 77030. To attend the meeting
virtually, please visit www.hhs.gov/live.
Dated: March 20, 2024.
Caroline Talev,
Senior Management Analyst, Office of
Infectious Disease and HIV/AIDS Policy,
Alternate Designated Federal Officer,
Presidential Advisory Council on HIV/AIDS,
Office of the Assistant Secretary for Health,
Department of Health and Human Services.
[FR Doc. 2024–06362 Filed 3–21–24; 4:15 pm]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
Frm 00038
Fmt 4703
Sfmt 4703
E:\FR\FM\25MRN1.SGM
25MRN1
Agencies
[Federal Register Volume 89, Number 58 (Monday, March 25, 2024)]
[Notices]
[Page 20666]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-06362]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Nominations for Membership on the Secretary's
Advisory Committee on Human Research Protections; Correction
AGENCY: Office of the Assistant Secretary for Health, Office for
Infectious Disease and HIV/AIDS Policy, Office of the Secretary,
Department of Health and Human Services (HHS).
ACTION: Notice; correction.
-----------------------------------------------------------------------
SUMMARY: HHS published a document in the Federal Register of March 12,
2024, announcing the Presidential Advisory Council on HIV/AIDS (PACHA)
80th full council meeting. Due to unforeseen circumstances, there has
been an update in meeting location.
FOR FURTHER INFORMATION CONTACT: Caroline Talev,
[email protected], (202) 795-7622.
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register of March 12, 2024, in FR Doc. 2024-05183,
on page 17859, third column, correct the addresses caption to read:
ADDRESSES: The public meeting will now be held at the UT School of
Public Health, 1200 Pressler Street in Houston, Texas 77030. To attend
the meeting virtually, please visit www.hhs.gov/live.
Dated: March 20, 2024.
Caroline Talev,
Senior Management Analyst, Office of Infectious Disease and HIV/AIDS
Policy, Alternate Designated Federal Officer, Presidential Advisory
Council on HIV/AIDS, Office of the Assistant Secretary for Health,
Department of Health and Human Services.
[FR Doc. 2024-06362 Filed 3-21-24; 4:15 pm]
BILLING CODE P